Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease

I. M. Reis, K. Ramachandran, C. Speer, E. Gordian, R. Singal

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease'. Together they form a unique fingerprint.

Medicine & Life Sciences